Fingerprints of brain disease: connectome identifiability in Alzheimer's disease.


Journal

Communications biology
ISSN: 2399-3642
Titre abrégé: Commun Biol
Pays: England
ID NLM: 101719179

Informations de publication

Date de publication:
18 Sep 2024
Historique:
received: 08 01 2024
accepted: 03 09 2024
medline: 19 9 2024
pubmed: 19 9 2024
entrez: 18 9 2024
Statut: epublish

Résumé

Functional connectivity patterns in the human brain, like the friction ridges of a fingerprint, can uniquely identify individuals. Does this "brain fingerprint" remain distinct even during Alzheimer's disease (AD)? Using fMRI data from healthy and pathologically ageing subjects, we find that individual functional connectivity profiles remain unique and highly heterogeneous during mild cognitive impairment and AD. However, the patterns that make individuals identifiable change with disease progression, revealing a reconfiguration of the brain fingerprint. Notably, connectivity shifts towards functional system connections in AD and lower-order cognitive functions in early disease stages. These findings emphasize the importance of focusing on individual variability rather than group differences in AD studies. Individual functional connectomes could be instrumental in creating personalized models of AD progression, predicting disease course, and optimizing treatments, paving the way for personalized medicine in AD management.

Identifiants

pubmed: 39294332
doi: 10.1038/s42003-024-06829-8
pii: 10.1038/s42003-024-06829-8
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1169

Informations de copyright

© 2024. The Author(s).

Références

Van Essen, D. C. et al. The human connectome project: a data acquisition perspective. Neuroimage 62, 2222–2231 (2012).
pubmed: 22366334 doi: 10.1016/j.neuroimage.2012.02.018
Van Essen, D. C. et al. The WU-minn human connectome project: an overview. Neuroimage 80, 62–79 (2013).
pubmed: 23684880 doi: 10.1016/j.neuroimage.2013.05.041
Weiner, M. W. et al. The Alzheimer’s disease neuroimaging initiative 3: continued innovation for clinical trial improvement. Alzheimer’s Dement. 13, 561–571 (2017).
doi: 10.1016/j.jalz.2016.10.006
Bullmore, E. & Sporns, O. Complex brain networks: graph theoretical analysis of structural and functional systems. Nat. Rev. Neurosci. 10, 186–198 (2009).
pubmed: 19190637 doi: 10.1038/nrn2575
Sporns, O. The human connectome: a complex network: the human connectome. Ann. N. Y. Acad. Sci. 1224, 109–125 (2011).
pubmed: 21251014 doi: 10.1111/j.1749-6632.2010.05888.x
Fornito, A., Zalesky, A. & Bullmore, E. Fundamentals of Brain Network Analyses (Academic Press, 2016).
Rocca, D. L. et al. Human brain distinctiveness based on EEG spectral coherence connectivity. IEEE Trans. Biomed. Eng. 61, 2406–2412 (2014).
pubmed: 24759981 doi: 10.1109/TBME.2014.2317881
Miranda-Dominguez, O. et al. Connectotyping: model based fingerprinting of the functional connectome. PLoS One 9, e111048 (2014).
pubmed: 25386919 pmcid: 4227655 doi: 10.1371/journal.pone.0111048
Finn, E. S. et al. Functional connectome fingerprinting: identifying individuals using patterns of brain connectivity. Nat. Neurosci. 18, 1664–1671 (2015).
pubmed: 26457551 pmcid: 5008686 doi: 10.1038/nn.4135
Demuru, M. & Fraschini, M. EEG fingerprinting: subject-specific signature based on the aperiodic component of power spectrum. Comput. Biol. Med. 120, 103748 (2020).
pubmed: 32421651 doi: 10.1016/j.compbiomed.2020.103748
Kong, W., Wang, L., Xu, S., Babiloni, F. & Chen, H. EEG fingerprints: phase synchronization of EEG signals as biomarker for subject identification. IEEE Access 7, 121165–121173 (2019).
doi: 10.1109/ACCESS.2019.2931624
Fraschini, M. et al. The effect of epoch length on estimated EEG functional connectivity and brain network organisation. J. Neural Eng. 13, 036015 (2016).
pubmed: 27137952 doi: 10.1088/1741-2560/13/3/036015
de Souza Rodrigues, J., Ribeiro, F. L., Sato, J. R., Mesquita, R. C. & Júnior, C. E. B. Identifying individuals using fNIRS-based cortical connectomes. Biomed. Opt. Express 10, 2889–2897 (2019).
pubmed: 31259059 pmcid: 6583329 doi: 10.1364/BOE.10.002889
da Silva Castanheira, J., Orozco Perez, H. D., Misic, B. & Baillet, S. Brief segments of neurophysiological activity enable individual differentiation. Nat. Commun. 12, 5713 (2021).
pubmed: 34588439 pmcid: 8481307 doi: 10.1038/s41467-021-25895-8
Sareen, E. et al. Exploring MEG brain fingerprints: evaluation, pitfalls, and interpretations. Neuroimage 240, 118331 (2021).
pubmed: 34237444 doi: 10.1016/j.neuroimage.2021.118331
Sorrentino, P. et al. Clinical connectome fingerprints of cognitive decline. Neuroimage 238, 118253 (2021).
pubmed: 34116156 doi: 10.1016/j.neuroimage.2021.118253
Troisi Lopez, E. et al. Fading of brain network fingerprint in Parkinson’s disease predicts motor clinical impairment. Hum. Brain Mapp. 44, 1239–1250 (2022).
pubmed: 36413043 pmcid: 9875937 doi: 10.1002/hbm.26156
Romano, A. et al. The progressive loss of brain network fingerprints in amyotrophic lateral sclerosis predicts clinical impairment. Neuroimage Clin. 35, 103095 (2022).
pubmed: 35764029 pmcid: 9241102 doi: 10.1016/j.nicl.2022.103095
Finn, E. S. & Rosenberg, M. D. Beyond fingerprinting: choosing predictive connectomes over reliable connectomes. Neuroimage 239, 118254 (2021).
pubmed: 34118397 doi: 10.1016/j.neuroimage.2021.118254
Rosenberg, M. D. et al. A neuromarker of sustained attention from whole-brain functional connectivity. Nat. Neurosci. 19, 165–171 (2016).
pubmed: 26595653 doi: 10.1038/nn.4179
Abbas, K. et al. GEFF: graph embedding for functional fingerprinting. Neuroimage 221, 117181 (2020).
pubmed: 32702487 doi: 10.1016/j.neuroimage.2020.117181
Amico, E. & Goñi, J. Mapping hybrid functional–structural connectivity traits in the human connectome. Netw. Neurosci. 2, 306–322 (2018).
pubmed: 30259007 pmcid: 6145853 doi: 10.1162/netn_a_00049
Bari, S., Amico, E., Vike, N., Talavage, T. M. & Goñi, J. Uncovering multi-site identifiability based on resting-state functional connectomes. Neuroimage 202, 115967 (2019).
pubmed: 31352124 doi: 10.1016/j.neuroimage.2019.06.045
Jirsa, V. K. et al. The virtual epileptic patient: individualized whole-brain models of epilepsy spread. Neuroimage 145, 377–388 (2017).
pubmed: 27477535 doi: 10.1016/j.neuroimage.2016.04.049
Liu, W., Kohn, N. & Fernández, G. Intersubject similarity of personality is associated with intersubject similarity of brain connectivity patterns. Neuroimage 186, 56–69 (2019).
pubmed: 30389630 doi: 10.1016/j.neuroimage.2018.10.062
Shen, X. et al. Using connectome-based predictive modeling to predict individual behavior from brain connectivity. Nat. Protoc. 12, 506–518 (2017).
pubmed: 28182017 pmcid: 5526681 doi: 10.1038/nprot.2016.178
Sui, J., Jiang, R., Bustillo, J. & Calhoun, V. Neuroimaging-based individualized prediction of cognition and behavior for mental disorders and health: methods and promises. Biol. Psychiatry 88, 818–828 (2020).
pubmed: 32336400 pmcid: 7483317 doi: 10.1016/j.biopsych.2020.02.016
Svaldi, D. O. et al. Optimizing differential identifiability improves connectome predictive modeling of cognitive deficits from functional connectivity in Alzheimer’s disease. Hum. Brain Mapp. 42, 3500–3516 (2021).
pubmed: 33949732 pmcid: 8249900 doi: 10.1002/hbm.25448
Palop, J. J., Chin, J. & Mucke, L. A network dysfunction perspective on neurodegenerative diseases. Nature 443, 768–773 (2006).
pubmed: 17051202 doi: 10.1038/nature05289
Delbeuck, X. Alzheimer’s disease as a disconnection syndrome? Neuropsychol. Rev. 13, 79–92 (2003).
Badhwar, A. et al. Resting‐state network dysfunction in Alzheimer’s disease: a systematic review and meta‐analysis. Alzheimer’s Dement. 8, 73–85 (2017).
Pievani, M., Filippini, N., van den Heuvel, M. P., Cappa, S. F. & Frisoni, G. B. Brain connectivity in neurodegenerative diseases—from phenotype to proteinopathy. Nat. Rev. Neurol. 10, 620–633 (2014).
pubmed: 25287597 doi: 10.1038/nrneurol.2014.178
Yu, M., Sporns, O. & Saykin, A. J. The human connectome in Alzheimer disease—relationship to biomarkers and genetics. Nat. Rev. Neurol. https://doi.org/10.1038/s41582-021-00529-1 (2021).
Agosta, F. et al. Resting state fMRI in Alzheimer’s disease: beyond the default mode network. Neurobiol. Aging 33, 1564–1578 (2012).
pubmed: 21813210 doi: 10.1016/j.neurobiolaging.2011.06.007
Stam, C. J. Modern network science of neurological disorders. Nat. Rev. Neurosci. 15, 683–695 (2014).
pubmed: 25186238 doi: 10.1038/nrn3801
Tijms, B. M. et al. Alzheimer’s disease: connecting findings from graph theoretical studies of brain networks. Neurobiol. Aging 34, 2023–2036 (2013).
pubmed: 23541878 doi: 10.1016/j.neurobiolaging.2013.02.020
Wang, K. et al. Altered functional connectivity in early Alzheimer’s disease: a resting-state fMRI study. Hum. Brain Mapp. 28, 967–978 (2007).
pubmed: 17133390 doi: 10.1002/hbm.20324
Brier, M. R. et al. Loss of intranetwork and internetwork resting state functional connections with Alzheimer’s disease progression. J. Neurosci. 32, 8890–8899 (2012).
pubmed: 22745490 pmcid: 3458508 doi: 10.1523/JNEUROSCI.5698-11.2012
Damoiseaux, J. S. Resting-state fMRI as a biomarker for Alzheimer’s disease? Alzheimers Res Ther. 4, 8 (2012).
pubmed: 22423634 pmcid: 3334541 doi: 10.1186/alzrt106
Jack, C. R. et al. Tracking pathophysiological processes in Alzheimer’s disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 12, 207–216 (2013).
pubmed: 23332364 pmcid: 3622225 doi: 10.1016/S1474-4422(12)70291-0
Schultz, A. P. et al. Phases of hyperconnectivity and hypoconnectivity in the default mode and salience networks track with amyloid and tau in clinically normal individuals. J. Neurosci. 37, 4323–4331 (2017).
pubmed: 28314821 pmcid: 5413178 doi: 10.1523/JNEUROSCI.3263-16.2017
Buckner, R. L. et al. Cortical hubs revealed by intrinsic functional connectivity: mapping, assessment of stability, and relation to Alzheimer’s disease. J. Neurosci. 29, 1860–1873 (2009).
pubmed: 19211893 pmcid: 2750039 doi: 10.1523/JNEUROSCI.5062-08.2009
Crossley, N. A. et al. The hubs of the human connectome are generally implicated in the anatomy of brain disorders. Brain 137, 2382–2395 (2014).
pubmed: 25057133 pmcid: 4107735 doi: 10.1093/brain/awu132
van den Heuvel, M. P. & Sporns, O. Network hubs in the human brain. Trends Cogn. Sci. 17, 683–696 (2013).
pubmed: 24231140 doi: 10.1016/j.tics.2013.09.012
Palmqvist, S. et al. Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity. Nat. Commun. 8, 1214 (2017).
pubmed: 29089479 pmcid: 5663717 doi: 10.1038/s41467-017-01150-x
Yu, M. et al. Selective impairment of hippocampus and posterior hub areas in Alzheimer’s disease: an MEG-based multiplex network study. Brain 140, 1466–1485 (2017).
pubmed: 28334883 doi: 10.1093/brain/awx050
Franzmeier, N. et al. Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease. Nat. Commun. 11, 347 (2020).
pubmed: 31953405 pmcid: 6969065 doi: 10.1038/s41467-019-14159-1
Frontzkowski, L. et al. Earlier Alzheimer’s disease onset is associated with tau pathology in brain hub regions and facilitated tau spreading. Nat. Commun. 13, 4899 (2022).
pubmed: 35987901 pmcid: 9392750 doi: 10.1038/s41467-022-32592-7
Franzmeier, N. et al. Functional connectivity associated with tau levels in ageing, Alzheimer’s, and small vessel disease. Brain 142, 1093–1107 (2019).
pubmed: 30770704 pmcid: 6439332 doi: 10.1093/brain/awz026
Franzmeier, N. et al. Patient-centered connectivity-based prediction of tau pathology spread in Alzheimer’s disease. Sci. Adv. 6, eabd1327 (2020).
Jack, C. R. et al. NIA-AA research framework: toward a biological definition of Alzheimer’s disease. Alzheimer’s Dement. 14, 535–562 (2018).
doi: 10.1016/j.jalz.2018.02.018
Power, J. D. et al. Methods to detect, characterize, and remove motion artifact in resting state fMRI. Neuroimage 84, 320–341 (2014).
pubmed: 23994314 doi: 10.1016/j.neuroimage.2013.08.048
Chiesa, P. A., Cavedo, E., Lista, S., Thompson, P. M. & Hampel, H. Revolution of resting-state functional neuroimaging genetics in Alzheimer’s Disease. Trends Neurosci. 40, 469–480 (2017).
pubmed: 28684173 pmcid: 5798613 doi: 10.1016/j.tins.2017.06.002
Shaw, L. M., Korecka, M., Clark, C. M., Lee, V. M.-Y. & Trojanowski, J. Q. Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics. Nat. Rev. Drug Discov. 6, 295–303 (2007).
pubmed: 17347655 doi: 10.1038/nrd2176
Cicchetti, D. V. Guidelines, criteria, and rules of thumb for evaluating normed and standardized assessment instruments in psychology. Psychol. Assess. 6, 284 (19950501).
Albert, M. S. et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s Dement. 7, 270–279 (2011).
doi: 10.1016/j.jalz.2011.03.008
Doraiswamy, P. M. et al. Florbetapir F18 amyloid PET and 36-month cognitive decline:a prospective multicenter study. Mol. Psychiatry 19, 1044–1051 (2014).
pubmed: 24614494 pmcid: 4195975 doi: 10.1038/mp.2014.9
Okello, A. et al. Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study. Neurology 73, 754–760 (2009).
pubmed: 19587325 pmcid: 2830881 doi: 10.1212/WNL.0b013e3181b23564
Braak, H. & Braak, E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82, 239–259 (1991).
pubmed: 1759558 doi: 10.1007/BF00308809
Jack, C. R. et al. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer’s disease. Neurology 49, 786–794 (1997).
pubmed: 9305341 doi: 10.1212/WNL.49.3.786
Preti, M. G. & Van De Ville, D. Decoupling of brain function from structure reveals regional behavioral specialization in humans. Nat. Commun. 10, 4747 (2019).
pubmed: 31628329 pmcid: 6800438 doi: 10.1038/s41467-019-12765-7
Margulies, D. S. & Smallwood, J. Converging evidence for the role of transmodal cortex in cognition. Proc. Natl. Acad. Sci. USA 114, 12641–12643 (2017).
pubmed: 29142008 pmcid: 5715795 doi: 10.1073/pnas.1717374114
Jones, D. T. et al. Cascading network failure across the Alzheimer’s disease spectrum. Brain 139, 547–562 (2016).
pubmed: 26586695 doi: 10.1093/brain/awv338
McKhann, G. M. et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging‐Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s Dement. 7, 263–269 (2011).
doi: 10.1016/j.jalz.2011.03.005
Liu, J., Liao, X., Xia, M. & He, Y. Chronnectome fingerprinting: identifying individuals and predicting higher cognitive functions using dynamic brain connectivity patterns. Hum. Brain Mapp. https://doi.org/10.1002/hbm.23890 .
Mueller, S. et al. Individual variability in functional connectivity architecture of the human brain. Neuron 77, 586–595 (2013).
pubmed: 23395382 pmcid: 3746075 doi: 10.1016/j.neuron.2012.12.028
Deco, G., Jirsa, V. K. & McIntosh, A. R. Emerging concepts for the dynamical organization of resting-state activity in the brain. Nat. Rev. Neurosci. 12, 43–56 (2011).
pubmed: 21170073 doi: 10.1038/nrn2961
Cole, M. W., Bassett, D. S., Power, J. D., Braver, T. S. & Petersen, S. E. Intrinsic and task-evoked network architectures of the human brain. Neuron 83, 238–251 (2014).
pubmed: 24991964 pmcid: 4082806 doi: 10.1016/j.neuron.2014.05.014
Garrett, D. D., Kovacevic, N., McIntosh, A. R. & Grady, C. L. Blood oxygen level-dependent signal variability is more than just noise. J. Neurosci. 30, 4914–4921 (2010).
pubmed: 20371811 pmcid: 6632804 doi: 10.1523/JNEUROSCI.5166-09.2010
Garrett, D. D., Kovacevic, N., McIntosh, A. R. & Grady, C. L. The importance of being variable. J. Neurosci. 31, 4496–4503 (2011).
pubmed: 21430150 pmcid: 3104038 doi: 10.1523/JNEUROSCI.5641-10.2011
Garrett, D. D., Kovacevic, N., McIntosh, A. R. & Grady, C. L. The modulation of BOLD variability between cognitive states varies by age and cognitive performance. Cereb. Cortex 23, 684–693 (2013).
pubmed: 22419679 doi: 10.1093/cercor/bhs055
Grothe, M. J. et al. In vivo staging of regional amyloid deposition. Neurology 89, 2031–2038 (2017).
pubmed: 29046362 pmcid: 5711511 doi: 10.1212/WNL.0000000000004643
Zhou, J. et al. Divergent network connectivity changes in behavioural variant frontotemporal dementia and Alzheimer’s disease. Brain 133, 1352–1367 (2010).
pubmed: 20410145 pmcid: 2912696 doi: 10.1093/brain/awq075
Birn, R. M. et al. The effect of scan length on the reliability of resting-state fMRI connectivity estimates. Neuroimage 83, 550–558 (2013).
pubmed: 23747458 doi: 10.1016/j.neuroimage.2013.05.099
Power, J. D., Barnes, K. A., Snyder, A. Z., Schlaggar, B. L. & Petersen, S. E. Spurious but systematic correlations in functional connectivity MRI networks arise from subject motion. Neuroimage 59, 2142–2154 (2012).
pubmed: 22019881 doi: 10.1016/j.neuroimage.2011.10.018
Van De Ville, D., Farouj, Y., Preti, M. G., Liégeois, R. & Amico, E. When makes you unique: temporality of the human brain fingerprint. Sci. Adv. 7, eabj0751 (2021).
Ribaldi, F. et al. Brain connectivity and metacognition in persons with subjective cognitive decline (COSCODE): rationale and study design. Alz Res Therapy 13, 105 (2021).
Dodich, A. et al. The A/T/N model applied through imaging biomarkers in a memory clinic. Eur. J. Nucl. Med Mol. Imaging 47, 247–255 (2020).
pubmed: 31792573 doi: 10.1007/s00259-019-04536-9
Klunk, W. E. et al. The centiloid project: standardizing quantitative amyloid plaque estimation by PET. Alzheimer’s Dement. 11, 1–15.e4 (2015).
doi: 10.1016/j.jalz.2014.07.003
Salvadó, G. et al. Centiloid cut-off values for optimal agreement between PET and CSF core AD biomarkers. Alzheimer's Res. Ther. 11, 27 (2019).
doi: 10.1186/s13195-019-0478-z
Amyvid. European Medicines Agency. Summary of Product Characteristics (accessed 13 October 2020); https://www.ema.europa.eu/en/documents/product-information/amyvid-epar-product-information_en.pdf
Vizamyl. European Medicines Agency. Summary of Product Characteristics (accessed 13 October 2020); https://www.ema.europa.eu/en/documents/product-information/vizamyl-epar-product-information_en.pdf
Landau, S. M. et al. Amyloid deposition, hypometabolism, and longitudinal cognitive decline. Ann. Neurol. 72, 578–586 (2012).
pubmed: 23109153 pmcid: 3786871 doi: 10.1002/ana.23650
Amico, E. et al. Mapping the functional connectome traits of levels of consciousness. Neuroimage 148, 201–211 (2017).
pubmed: 28093358 doi: 10.1016/j.neuroimage.2017.01.020
Coupé, P., Manjón, J. V., Robles, M. & Collins, D. L. Adaptive multiresolution non-local means filter for three-dimensional magnetic resonance image denoising. IET Image Process 6, 558 (2012).
doi: 10.1049/iet-ipr.2011.0161
Richiardi, J. et al. Classifying minimally disabled multiple sclerosis patients from resting state functional connectivity. Neuroimage 62, 2021–2033 (2012).
pubmed: 22677149 doi: 10.1016/j.neuroimage.2012.05.078
Jenkinson, M., Bannister, P., Brady, M. & Smith, S. Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage 17, 825–841 (2002).
pubmed: 12377157 doi: 10.1006/nimg.2002.1132
Griffa, A., Amico, E., Liégeois, R., Van De Ville, D. & Preti, M. G. Brain structure-function coupling provides signatures for task decoding and individual fingerprinting. Neuroimage 250, 118970 (2022).
pubmed: 35124226 doi: 10.1016/j.neuroimage.2022.118970
Shen, X., Tokoglu, F., Papademetris, X. & Constable, R. T. Groupwise whole-brain parcellation from resting-state fMRI data for network node identification. Neuroimage 82, 403–415 (2013).
pubmed: 23747961 doi: 10.1016/j.neuroimage.2013.05.081
Greve, D. N. & Fischl, B. Accurate and robust brain image alignment using boundary-based registration. Neuroimage 48, 63–72 (2009).
pubmed: 19573611 doi: 10.1016/j.neuroimage.2009.06.060
Yeo, B. T. T. et al. The organization of the human cerebral cortex estimated by intrinsic functional connectivity. J. Neurophysiol. 106, 41 (2011).
Amico, E. et al. The disengaging brain: dynamic transitions from cognitive engagement and alcoholism risk. Neuroimage 209, 116515 (2020).
pubmed: 31904492 doi: 10.1016/j.neuroimage.2020.116515
McGraw, K. O. & Wong, S. P. Forming inferences about some intraclass correlation coefficients. Psychol. Methods. https://doi.org/10.1037/1082-989X/96/S3.00 (1996).
Koch, G. G. Intraclass correlation coefficient. Wiley StatsRef: Statistics Reference Online 7. https://doi.org/10.1002/9781118445112.stat02461 (2014).
Somandepalli, K. et al. Short-term test–retest reliability of resting state fMRI metrics in children with and without attention-deficit/hyperactivity disorder. Dev. Cogn. Neurosci. 15, 83–93 (2015).
pubmed: 26365788 pmcid: 6989828 doi: 10.1016/j.dcn.2015.08.003
Shehzad, Z. et al. The resting brain: unconstrained yet reliable. Cereb. Cortex 19, 2209–2229 (2009).
pubmed: 19221144 pmcid: 3896030 doi: 10.1093/cercor/bhn256
Shah, L. M., Cramer, J. A., Ferguson, M. A., Birn, R. M. & Anderson, J. S. Reliability and reproducibility of individual differences in functional connectivity acquired during task and resting state. Brain Behav. 6, e00456 (2016).
pubmed: 27069771 pmcid: 4814225 doi: 10.1002/brb3.456
Noble, S., Scheinost, D. & Constable, R. T. A decade of test–retest reliability of functional connectivity: a systematic review and meta-analysis. Neuroimage 203, 116157 (2019).
pubmed: 31494250 doi: 10.1016/j.neuroimage.2019.116157
Cicchetti, D. V. & Sparrow, S. A. Developing criteria for establishing interrater reliability of specific items: applications to assessment of adaptive behavior. Am. J. Ment. Defic. 86, 127–137 (1981).
pubmed: 7315877
Xia, M., Wang, J. & He, Y. BrainNet viewer: a network visualization tool for human brain connectomics. PLoS One 8, e68910 (2013).
pubmed: 23861951 pmcid: 3701683 doi: 10.1371/journal.pone.0068910
Horien, C., Shen, X., Scheinost, D. & Constable, R. T. The individual functional connectome is unique and stable over months to years. Neuroimage 189, 676–687 (2019).
pubmed: 30721751 doi: 10.1016/j.neuroimage.2019.02.002
R Core Team. R: A Language And Environment For Statistical Computing. R Foundation for Statistical Computing, Vienna (2020).
The MathWorks Inc. MATLAB.
Frossard, J. & Renaud, O. Permutation tests for regression, ANOVA, and comparison of signals: the permuco package. J. Stat. Softw. https://doi.org/10.18637/jss.v099.i15 (2021).

Auteurs

Sara Stampacchia (S)

Neuro-X Institute and Brain Mind Institute (BMI), École Polytechnique Fédérale de Lausanne (EPFL), Geneva, Switzerland. sara.stampacchia@epfl.ch.

Saina Asadi (S)

Department of Radiology and Medical Informatics, Geneva University Neurocenter, University of Geneva, Geneva, Switzerland.

Szymon Tomczyk (S)

Laboratory of Neuroimaging of Aging (LANVIE), University of Geneva, Geneva, Switzerland.

Federica Ribaldi (F)

Laboratory of Neuroimaging of Aging (LANVIE), University of Geneva, Geneva, Switzerland.
Geneva Memory Center, Department of Rehabilitation and Geriatrics, Geneva University Hospitals, Geneva, Switzerland.

Max Scheffler (M)

Division of Radiology, Geneva University Hospitals, Geneva, Switzerland.

Karl-Olof Lövblad (KO)

Department of Radiology and Medical Informatics, Geneva University Neurocenter, University of Geneva, Geneva, Switzerland.
Neurodiagnostic and Neurointerventional Division, Geneva University Hospitals, Geneva, Switzerland.

Michela Pievani (M)

Lab of Alzheimer's Neuroimaging and Epidemiology, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy.

Aïda B Fall (AB)

Faculty of Medicine, University of Geneva, Geneva, Switzerland.
CIBM Center for Biomedical Imaging, Lausanne, Switzerland.
Department of Psychiatry, Geneva University Hospitals, Geneva, Switzerland.

Maria Giulia Preti (MG)

Neuro-X Institute and Brain Mind Institute (BMI), École Polytechnique Fédérale de Lausanne (EPFL), Geneva, Switzerland.
Department of Radiology and Medical Informatics, Geneva University Neurocenter, University of Geneva, Geneva, Switzerland.
CIBM Center for Biomedical Imaging, Lausanne, Switzerland.

Paul G Unschuld (PG)

Division of Geriatric Psychiatry, University Hospitals of Geneva (HUG), 1226, Thônex, Switzerland.
Department of Psychiatry, University of Geneva (UniGE), 1205, Geneva, Switzerland.

Dimitri Van De Ville (D)

Neuro-X Institute and Brain Mind Institute (BMI), École Polytechnique Fédérale de Lausanne (EPFL), Geneva, Switzerland.
Department of Radiology and Medical Informatics, Geneva University Neurocenter, University of Geneva, Geneva, Switzerland.

Olaf Blanke (O)

Neuro-X Institute and Brain Mind Institute (BMI), École Polytechnique Fédérale de Lausanne (EPFL), Geneva, Switzerland.

Giovanni B Frisoni (GB)

Laboratory of Neuroimaging of Aging (LANVIE), University of Geneva, Geneva, Switzerland.
Geneva Memory Center, Department of Rehabilitation and Geriatrics, Geneva University Hospitals, Geneva, Switzerland.

Valentina Garibotto (V)

Department of Radiology and Medical Informatics, Geneva University Neurocenter, University of Geneva, Geneva, Switzerland.
CIBM Center for Biomedical Imaging, Lausanne, Switzerland.
Division of Nuclear Medicine and Molecular Imaging, Geneva University Hospitals, Geneva, Switzerland.

Enrico Amico (E)

Neuro-X Institute and Brain Mind Institute (BMI), École Polytechnique Fédérale de Lausanne (EPFL), Geneva, Switzerland. e.amico@bham.ac.uk.
School of Mathematics, University of Birmingham, Birmingham, UK. e.amico@bham.ac.uk.
Centre for Human Brain Health, University of Birmingham, Birmingham, UK. e.amico@bham.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH